UNH's dip to $250 offers a strong buy opportunity with solid revenue growth, resilient dividends, and historic low P/E.

Relevance, delivering best-in-class search and generative experiences that maximize business outcomes at every point-of-experience, today announced financial results for its fourth quarter and fiscal ...

UnitedHealth Group’s stock just got a professional downgrade from TD Cowen, shifting from a “buy” to a “hold.” This shift ...